03:08 PM EDT, 04/29/2024 (MT Newswires) -- ClearPoint Neuro ( CLPT ) said Monday it received 510(k) approval from the US Food and Drug Administration for its Prism Bone Anchor Accessory.

The Prism Bone Anchor Accessory is designed for use with stereotactic systems in intracranial and neurosurgical procedures, offering precise positioning of small surgical instruments in the cranium, brain, or nervous system.

The company plans to start limited market release in Q2, with a full market release in H2, Chris Osswald, an executive at ClearPoint, said.

Price: 5.25, Change: -0.01, Percent Change: -0.29